Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toxin determinants required for interaction with voltage-gated K+ channels.

Besma Jouirou1, Stéphanie Mouhat, Nicolas Andreotti

  • 1Laboratoire d'Ingénierie des Protéines, Faculte de Medecine Secteur Nord, CNRS FRE 2738, Bd Pierre Dramard, 13916 Marseille, France.

Toxicon : Official Journal of the International Society on Toxinology
|June 23, 2004
PubMed
Summary

Animal toxins like scorpion and snake venoms contain short peptides that target ion channels. This review focuses on peptides acting on potassium channels, exploring their structure-activity relationships for potential drug development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent advances in venom pharmacology reshaping venom-to-drug discovery.

Trends in pharmacological sciences·2026
Same author

Retraction notice to "Attenuation of hyperglycemia-associated dyslipidemic, oxidative, cognitive, and inflammatory crises via modulation of neuronal ChEs/NF-κB/COX-2/NOx, and hepatorenal functional deficits by the Tridax procumbens extract" [Biomedicine & Pharmacotherapy 158 (2023) 114114].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

SPARC: a structural pathogenicity algorithm for risk classification of hERG variants.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2025
Same author

Electrophysiological classification of <i>CACNA1G</i> gene variants associated with neurodevelopmental and neurological disorders.

Frontiers in pharmacology·2025
Same author

Cyanine 5-huwentoxin-IV as a novel imaging probe to detect hNa<sub>v</sub>1.7 channel overexpressed in non-small cell lung cancer.

Biochemical pharmacology·2025
Same author

Cytotoxic Activity of Essential Oils from Middle Eastern Medicinal Plants on Malignant Keratinocytes.

Molecules (Basel, Switzerland)·2025

Area of Science:

  • Biochemistry
  • Pharmacology
  • Evolutionary Biology

Background:

  • Animal venoms contain diverse short peptides that target ion channels.
  • These peptides exhibit convergent evolution, suggesting conserved molecular targets and functions.
  • Toxins often interact with ion channels and ligand-gated receptors, with some targeting enzymes.

Purpose of the Study:

  • To review selected animal peptides that modulate voltage-gated potassium (K+) channels.
  • To analyze the structural determinants responsible for toxin recognition and binding to specific K+ channel pore structures.
  • To correlate structural features with the efficacy of blocking K+ efflux.

Main Methods:

  • Literature review of ion channel-acting peptides from various animal sources.

Related Experiment Videos

  • Analysis of structural motifs and molecular determinants of toxin-channel interactions.
  • Correlation of structural properties with functional outcomes, specifically K+ channel blockade.

    • Main Results:

    • Identified conserved structural features in peptides targeting K+ channels across different species.
    • Demonstrated that specific molecular determinants dictate the recognition of K+ channel pore structures.
    • Established a link between toxin structure and the efficiency of blocking K+ ion efflux.

    Conclusions:

    • Understanding the structural basis of toxin-channel interaction is crucial for K+ channel modulation.
    • These insights can guide the development of novel peptide-based pharmaceuticals with specific pharmacological properties.
    • Convergent evolution highlights common targets and mechanisms in toxin research.